Results 91 to 100 of about 44,694 (144)
【目的】 在大鼠70%肝部分切除基础上建立入肝门静脉动脉化加门腔分流术的模型,并研究大鼠肝脏再生情况65377;【方法】 155只Sprague-Dawley大鼠分为3组65377;实验组大鼠65只,利用右肾动脉行入肝门静脉动脉化,并行门腔分流及肝部分切除,肝切组大鼠65只,仅进行肝部分切除,对照组大鼠25只,仅右肾切除65377;分别观察实验组及肝切组术后265380;765380;14及28 d残肝再生比率变化,以及3组在术中0 h65380;术后2465380;4865380;72 h及7 ...
core
[Liver-bone axis: novel mechanisms and strategies for MAFLD regulation]. [PDF]
Wang YW, Yan XZ, You H, Yang AT.
europepmc +1 more source
[Emphasis on the prevention and treatment of hepatic vascular diseases]. [PDF]
Tang CW.
europepmc +1 more source
【目的】 采用CT灌注成像的方法评价不同途径移植肝细胞对肝硬化大鼠模型肝脏血流灌注的影响,进而筛选出针对肝硬化大鼠模型安全,有效的细胞移植途径。【方法】 50只经证实成模的肝硬化大鼠模型随机分为5组,前4组分别自肝动脉、门静脉、脾动脉及尾静脉移植肝细胞悬液2 mL(细胞数量2 × 106),对照组不干预,各组大鼠在细胞移植前1周及移植后第4、8周行CT灌注扫描,计算肝动脉灌注量(HAP)、门静脉灌注量(PVP)、总肝灌注量(THBP)等参数,死亡大鼠或第8周后处死大鼠取肝脏、肺行病理切片检查。【结果 ...
core
[Research progresses in ex vivo liver perfusion technology]. [PDF]
Liu QY, Zhao Q, He XS.
europepmc +1 more source
[Liver manifestation of circulatory disorders]. [PDF]
Wang Y +6 more
europepmc +1 more source
[Clinical strategies and indication expansion of interventional ultrasonography ablative therapy for hepatic tumors]. [PDF]
Liang YG, Wang HY, Zhao QY, Jiang TA.
europepmc +1 more source
[Clinicopathological characteristics and key therapeutic options for liver involvement with vasculitis]. [PDF]
Chen SY, Zhao XY.
europepmc +1 more source
[IOX1 alleviates hepatic ischemia-reperfusion injury by inhibiting mitogen-activated protein kinase signaling pathway]. [PDF]
Hu SC +7 more
europepmc +1 more source
[Hepatic manifestations of hematological diseases]. [PDF]
Shan S, Zhao XY, Jia JD.
europepmc +1 more source

